Emergent BioSolutions Inc. - EBS
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Apr 03, 2026 | SVP, Products Business | S | D | 4,000.0 | 8.44 | 33,760.0 | 62,681.0 | View | |
| Mar 06, 2026 | EVP, Chief Financial Officer | H | D | 20,321.0 | 0.0 | 0.0 | 0.0 | View | |
| Mar 06, 2026 | EVP, Chief Financial Officer | H | D | 19,963.0 | 0.0 | 0.0 | 0.0 | View | |
| Mar 05, 2026 | EVP, Quality & Ethics, and CPL | A | A | 44,834.0 | 0.0 | 0.0 | 294,447.0 | View | |
| Mar 05, 2026 | EVP, Quality & Ethics, and CPL | F | D | 8,199.0 | 8.44 | 69,199.56 | 104,108.0 | View | |
| Mar 05, 2026 | EVP, Chief Financial Officer | A | A | 72,856.0 | 0.0 | 0.0 | 557,346.0 | View | |
| Mar 05, 2026 | EVP, Chief Financial Officer | F | D | 23,650.0 | 8.44 | 199,606.0 | 215,367.0 | View | |
| Mar 05, 2026 | SVP, Products Business | A | A | 44,834.0 | 0.0 | 0.0 | 254,948.0 | View | |
| Mar 05, 2026 | SVP, Products Business | F | D | 9,397.0 | 8.44 | 79,310.68 | 66,681.0 | View | |
| Mar 05, 2026 | SVP, General Counsel, Corp Sec | A | A | 46,702.0 | 0.0 | 0.0 | 142,647.0 | View | |
| Mar 05, 2026 | SVP, General Counsel, Corp Sec | F | D | 6,465.0 | 8.44 | 54,564.6 | 61,004.0 | View | |
| Mar 05, 2026 | SVP, Bioservices | A | A | 44,834.0 | 0.0 | 0.0 | 259,545.0 | View | |
| Mar 05, 2026 | SVP, Bioservices | F | D | 9,493.0 | 8.44 | 80,120.92 | 87,188.0 | View | |
| Mar 05, 2026 | SVP, R&D, CMO | A | A | 44,834.0 | 0.0 | 0.0 | 147,833.0 | View | |
| Mar 05, 2026 | SVP, R&D, CMO | F | D | 10,636.0 | 8.44 | 89,767.84 | 77,803.0 | View | |
| Mar 05, 2026 | — | A | A | 5,006.0 | 8.99 | 45,003.94 | 5,006.0 | View | |
| Mar 05, 2026 | President and CEO | A | A | 252,194.0 | 0.0 | 0.0 | 1,784,694.0 | View | |
| Mar 05, 2026 | President and CEO | F | D | 37,055.0 | 8.44 | 312,744.2 | 305,445.0 | View | |
| Mar 03, 2026 | EVP, Chief Financial Officer | F | D | 683.0 | 8.15 | 5,566.45 | 239,017.0 | View | |
| Mar 03, 2026 | SVP, Products Business | F | D | 116.0 | 8.15 | 945.4 | 76,078.0 | View | |
| Mar 03, 2026 | EVP, Quality & Ethics, and CPL | F | D | 313.0 | 8.15 | 2,550.95 | 112,307.0 | View | |
| Feb 10, 2026 | EVP, Chief Financial Officer | F | D | 5,642.0 | 10.92 | 61,610.64 | 239,700.0 | View | |
| Feb 10, 2026 | EVP, Chief Financial Officer | D | D | 46,155.0 | 10.92 | 504,012.6 | 245,342.0 | View | |
| Feb 10, 2026 | SVP, General Counsel, Corp Sec | F | D | 918.0 | 11.03 | 10,125.54 | 67,469.0 | View | |
| Feb 10, 2026 | SVP, Products Business | F | D | 1,022.0 | 10.92 | 11,160.24 | 76,194.0 | View | |
| Feb 10, 2026 | SVP, Products Business | D | D | 8,655.0 | 10.92 | 94,512.6 | 77,216.0 | View | |
| Feb 10, 2026 | SVP, Bioservices | F | D | 630.0 | 10.92 | 6,879.6 | 96,681.0 | View | |
| Feb 10, 2026 | SVP, Bioservices | D | D | 5,771.0 | 10.92 | 63,019.32 | 97,311.0 | View | |
| Feb 10, 2026 | EVP, Quality & Ethics, and CPL | F | D | 2,852.0 | 10.92 | 31,143.84 | 112,620.0 | View | |
| Feb 10, 2026 | EVP, Quality & Ethics, and CPL | D | D | 28,847.0 | 10.92 | 315,009.24 | 115,472.0 | View | |
| Dec 16, 2025 | SVP, R&D, CMO | F | D | 3,543.0 | 11.41 | 40,425.63 | 88,439.0 | View | |
| Dec 09, 2025 | — | M | D | 25,748.0 | 0.0 | 0.0 | 0.0 | View | |
| Dec 09, 2025 | — | S | D | 14,884.0 | 11.8978 | 177,086.86 | 98,417.0 | View | |
| Dec 09, 2025 | — | F | D | 10,864.0 | 11.8978 | 129,257.7 | 113,301.0 | View | |
| Dec 09, 2025 | — | M | A | 25,748.0 | 5.02 | 129,254.96 | 124,165.0 | View | |
| Dec 09, 2025 | — | S | D | 7,100.0 | 12.1113 | 85,990.23 | 98,417.0 | View | |
| Nov 13, 2025 | SVP, Bioservices | F | D | 610.0 | 10.88 | 6,636.8 | 103,082.0 | View | |
| Nov 12, 2025 | — | S | D | 17,801.0 | 10.54 | 187,622.54 | 119,858.0 | View | |
| Nov 10, 2025 | — | S | D | 8,552.0 | 10.0 | 85,520.0 | 88,980.0 | View | |
| Oct 17, 2025 | EVP, Chief Financial Officer | F | D | 4,995.0 | 9.6 | 47,952.0 | 291,497.0 | View | |
| Oct 16, 2025 | EVP, Quality & Ethics, and CPL | S | D | 30,608.0 | 10.0 | 306,080.0 | 144,319.0 | View |